-
Current guidelines recommend monotherapy with either beta-blockers or rate lowering calcium blockers for heart rate control in patients with permanent atrial fibrillation (AF).
-
This was a retrospective cohort study from Quebec and Ontario, Canada, examining patients ≥ 65 years of age admitted to a hospital with a diagnosis of atrial fibrillation (AF) between 1998 and 2007.
-
Beta-blockers have long been considered a cornerstone of therapy for patients with acute myocardial infarction (MI).
-
Resistant hypertension, defined as a systolic blood pressure (BP) that remains above goal despite treatment with at least three complementary antihypertensive agents of different classes at maximally tolerated doses, has become an increasingly common diagnosis in recent years.
-
Coronary artery stents are implanted in the vast majority of coronary revascularization procedures, owing to improvements in both restenosis and acute vessel occlusion vs balloon angioplasty alone.
-
The cause of ischemic stroke remains uncertain despite a complete diagnostic evaluation in many cases. Detection of atrial fibrillation (AF) after cryptogenic stroke would have important therapeutic implications.
-
The clinical implications of the recovery of left ventricular (LV) function after treatment of patients with initial systolic heart failure is poorly understood.
-
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and has been the leading arrhythmic cause for hospitalization.
-
The optimal treatment for ischemic mitral regurgitation (MR) is controversial and suffers from a lack of sufficient study data to build a consensus.
-
It is believed that right ventricular (RV) performance in acute pulmonary embolism patients is of prognostic value, but specific RV function parameters are not agreed upon and there are little outcome data in this area.
